1. Aerosolised ribavirin - postmarketing surveillance in the USA

   Newsletter Article 27 January 2013 Pages: 1 - 1

2. Safety of ketoprofen in the elderly

   Newsletter Article 27 January 2013 Pages: 1 - 1

3. Mesalazine - an improved safety profile vs sulfasalazine

   Newsletter Article 27 January 2013 Pages: 2 - 2

4. Antihistamine-induced impairment of function

   Newsletter Article 27 January 2013 Pages: 2 - 3

5. Drug Information Specialists/Scientific Writers to work in New Zealand

   Newsletter Article 27 January 2013 Pages: 3 - 3

6. Acetarsol

   Newsletter Article 27 January 2013 Pages: 4 - 4

7. Allopurinol withdrawal

   Newsletter Article 27 January 2013 Pages: 4 - 4

8. Alprazolam withdrawal

   Newsletter Article 27 January 2013 Pages: 4 - 4

9. Amantadine

   Newsletter Article 27 January 2013 Pages: 4 - 4

10. Amineptine abuse

    Newsletter Article 27 January 2013 Pages: 4 - 4

11. Aminoglycosides

    Newsletter Article 27 January 2013 Pages: 4 - 4

12. Amiodarone

    Newsletter Article 27 January 2013 Pages: 4 - 5

13. Anticonvulsant interactions

    Newsletter Article 27 January 2013 Pages: 5 - 5

14. Antineoplastics

    Newsletter Article 27 January 2013 Pages: 5 - 5

15. Baclofen

    Newsletter Article 27 January 2013 Pages: 5 - 5

16. Calcium antagonist interactions

    Newsletter Article 27 January 2013 Pages: 5 - 5

17. Carbamazepine

    Newsletter Article 27 January 2013 Pages: 5 - 5

18. Ceftriaxone

    Newsletter Article 27 January 2013 Pages: 5 - 5

19. Charcoal/sorbitol

    Newsletter Article 27 January 2013 Pages: 6 - 6

20. Ciprofloxacin

    Newsletter Article 27 January 2013 Pages: 6 - 6

21. Cisplatin

    Newsletter Article 27 January 2013 Pages: 6 - 6

22. Cyclosporin interaction

    Newsletter Article 27 January 2013 Pages: 6 - 6

23. Danazol

    Newsletter Article 27 January 2013 Pages: 7 - 7

24. Desmopressin

    Newsletter Article 27 January 2013 Pages: 7 - 7

25. Diclofenac/tenoxicam

    Newsletter Article 27 January 2013 Pages: 7 - 7

26. Digitoxin poisoning

    Newsletter Article 27 January 2013 Pages: 7 - 7

27. Diltiazem see Cyclosporin interaction

    Newsletter Article 27 January 2013 Pages: 7 - 7

28. Enalapril

    Newsletter Article 27 January 2013 Pages: 7 - 7

29. Formaldehyde

    Newsletter Article 27 January 2013 Pages: 7 - 7

30. Heparin

    Newsletter Article 27 January 2013 Pages: 7 - 7

31. Hydromorphone/morphine

    Newsletter Article 27 January 2013 Pages: 7 - 8

32. Interferon gamma

    Newsletter Article 27 January 2013 Pages: 8 - 8

33. Lovastatin

    Newsletter Article 27 January 2013 Pages: 8 - 8

34. Mefloquine

    Newsletter Article 27 January 2013 Pages: 8 - 8

35. Mesalazine

    Newsletter Article 27 January 2013 Pages: 9 - 9

36. Methylprednisolone

    Newsletter Article 27 January 2013 Pages: 9 - 9

37. Morphine see Hydromorphone/morphine

    Newsletter Article 27 January 2013 Pages: 9 - 9

38. Nitroglycerin poisoning

    Newsletter Article 27 January 2013 Pages: 9 - 9

39. Omega 3 fatty acid

    Newsletter Article 27 January 2013 Pages: 9 - 9

40. Papaverine

    Newsletter Article 27 January 2013 Pages: 9 - 9

41. Pentamidine

    Newsletter Article 27 January 2013 Pages: 9 - 10

42. Phenytoin interaction

    Newsletter Article 27 January 2013 Pages: 10 - 10

43. Pristinamycin see Cyclosporin interaction

    Newsletter Article 27 January 2013 Pages: 10 - 10

44. Propofol

    Newsletter Article 27 January 2013 Pages: 10 - 10

45. Scopolamine

    Newsletter Article 27 January 2013 Pages: 10 - 10

46. Scopolamine withdrawal

    Newsletter Article 27 January 2013 Pages: 10 - 10

47. Semustine

    Newsletter Article 27 January 2013 Pages: 10 - 11

48. Sodium aurotiosulfate

    Newsletter Article 27 January 2013 Pages: 11 - 11

49. Sorbitol see Charcoal/sorbitol

    Newsletter Article 27 January 2013 Pages: 11 - 11

50. Sulpiride

    Newsletter Article 27 January 2013 Pages: 11 - 11